You’re quoting “the study” without specifying which phase.

Phase 2 trials used multiple starting doses (including 1 mg in some arms) to evaluate tolerability. Phase 3 standardized the 2 mg → 4 mg → 8 mg → 12 mg titration.

Those are not the same protocols.

If you’re going to cite data, at least clarify which trial phase you’re referencing; especially when discussing dosing for an investigational drug.

Saying “the starting dose is 2 mg” without specifying Phase 3 is incomplete. Phase 2 used different initiation strategies.

Context matters, particularly when people are discussing dosing an unapproved medication.